Usability of FDA-Approved Medication Guides

被引:43
|
作者
Wolf, Michael S. [1 ,2 ]
King, Jennifer [1 ]
Wilson, Elizabeth A. H. [1 ]
Curtis, Laura M. [1 ]
Bailey, Stacy Cooper [1 ]
Duhig, James [3 ]
Russell, Allison [1 ]
Bergeron, Ashley [1 ]
Daly, Amanda [1 ]
Parker, Ruth M. [4 ]
Davis, Terry C. [5 ]
Shrank, William H. [6 ]
Lambert, Bruce [3 ]
机构
[1] Northwestern Univ, Hlth Literacy & Learning Program, Div Gen Internal Med, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Learning Sci, Sch Educ & Social Policy, Evanston, IL USA
[3] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL USA
[4] Emory Univ, Sch Med, Div Gen Med, Atlanta, GA USA
[5] Louisiana State Univ, Dept Med Pediat, Hlth Sci Ctr, Shreveport, LA 71105 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
关键词
prescription; medication information; comprehension; FDA; medication guide; health literacy; RISK-EVALUATION; LITERACY; VARIABILITY; INFORMATION; LANGUAGE;
D O I
10.1007/s11606-012-2068-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Medication guides are required documents to be distributed to patients in order to convey serious risks associated with certain prescribed medicines. Little is known about the effectiveness of this information to adequately inform patients on safe use. OBJECTIVE: To examine the readability, suitability, and comprehensibility of medication guides, particularly for those with limited literacy. DESIGN: Assessments of suitability and readability of 185 medication guides, and a sub-study examining change in suitability and readability from 2006 to 2010 among 32 of the medication guides (Study 1); 'open book' comprehension assessment of medication guides (Study 2). SETTING: Two general internal medicine clinics in Chicago, IL. PATIENTS: Four hundred and forty-nine adults seeking primary care services, ages 18-85. MEASUREMENTS: For Study 1, the Suitability Assessment of Materials (SAM) and Lexile score for readability. For Study 2, a tailored comprehension assessment of content found in three representative medication guides. RESULTS: The 185 analyzed medication guides were on average 1923 words (SD = 1022), with a mean reading level of 10-11th grade. Only one medication guide was deemed suitable in SAM analyses. None provided summaries or reviews, or framed the context first, while very few were rated as having made the purpose evident (8 %), or limited the scope of content (22 %). For Study 2, participants' comprehension of medication guides was poor (M = 52.7 % correct responses, SD = 22.6). In multivariable analysis, low and marginal literacy were independently associated with poorer understanding (beta = -14.3, 95 % CI -18.0 - -10.6, p < 0.001; low: beta = -23.7, 95 % CI -28.3 - -19.0, p < 0.001). CONCLUSION: Current medication guides are of little value to patients, as they are too complex and difficult to understand especially for individuals with limited literacy. Explicit guidance is offered for improving these print materials.
引用
收藏
页码:1714 / 1720
页数:7
相关论文
共 50 条
  • [1] Usability of FDA-Approved Medication Guides
    Michael S. Wolf
    Jennifer King
    Elizabeth A. H. Wilson
    Laura M. Curtis
    Stacy Cooper Bailey
    James Duhig
    Allison Russell
    Ashley Bergeron
    Amanda Daly
    Ruth M. Parker
    Terry C. Davis
    William H. Shrank
    Bruce Lambert
    Journal of General Internal Medicine, 2012, 27 : 1714 - 1720
  • [2] A critical review of FDA-approved medication guides
    Wolf, Michael S.
    Davis, Terry C.
    Shrank, William H.
    Neuberger, Marolee
    Parker, Ruth M.
    PATIENT EDUCATION AND COUNSELING, 2006, 62 (03) : 316 - 322
  • [3] Evaluating the readability of FDA-approved JAK inhibitor medication guides in dermatology
    Lau, William C.
    Lau, Charles B.
    Nambudiri, Vinod
    Smith, Gideon P.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [4] FDA-APPROVED INDICATIONS
    ANDERSON, DA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (11): : 2328 - 2328
  • [5] FDA-Approved Antibacterials and Echinocandins
    Al Musaimi, Othman
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [6] Recent changes to FDA-approved labelling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1766 - 1766
  • [7] Target selection for FDA-approved medicines
    Kinch, Michael S.
    Hoyer, Denton
    Patridge, Eric
    Plummer, Mark
    DRUG DISCOVERY TODAY, 2015, 20 (07) : 784 - 789
  • [8] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (09) : 828 - 828
  • [9] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (12) : 1242 - +
  • [10] Recent changes to FDA-approved labeling
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (08) : 742 - 742